Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
November 06, 2023 16:14 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
November 06, 2023 15:56 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 November 2023 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2023 of DKK 30 billion continues. As part of this, Novo Nordisk A/S has now initiated a...
Novo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programme
November 06, 2023 15:49 ET
|
Novo Nordisk A/S
Novo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programm – Today, Novo Nordisk A/S has entered into an agreement to purchase...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
November 06, 2023 08:40 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
November 03, 2023 10:18 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 3 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023
November 02, 2023 02:30 ET
|
Novo Nordisk A/S
Bagsværd 2 November 2023 - Financial report for the period 1 January 2023 to 30 September 2023 ...
Novo Nordisk A/S - share repurchase programme
November 01, 2023 12:04 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 November 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
October 23, 2023 08:51 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 23 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S – Share repurchase programme
October 16, 2023 08:09 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 16 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences
October 16, 2023 07:00 ET
|
Novo Nordisk A/S
Bagsværd, Denmark and Singapore, 16 October 2023 – Novo Nordisk A/S and KBP Biosciences PTE., Ltd. today announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension...